Literature DB >> 17344575

Prevalence and risk factors of fatty liver disease in the Shuiguohu district of Wuhan city, central China.

Zhongli Wang1, Bing Xia, Chunwei Ma, Zhengguo Hu, Xiangqun Chen, Ping Cao.   

Abstract

BACKGROUND: Fatty liver disease (FLD) is highly prevalent in Western countries, but recent data have shown that FLD is also emerging in China. AIM: To investigate the prevalence and risk factors of FLD in the Shuiguohu district of Wuhan city, central China, during 1995-2004.
METHODS: 12247 individuals (7179 men and 5068 women) over 18 years of age who were living in the area were investigated for FLD in the Zhongnan Hospital of Wuhan University from 1995 to 2004. FLD was determined by the ultrasonographic method. Height, weight, blood pressure, fasting blood sugar, alanine aminotransferase, total cholesterol and triglyceride were determined by routine laboratory methods.
RESULTS: The prevalence of FLD was 12.5% in 1995, and rose gradually to 24.5% by 2003-4. The prevalence was twice as high in men (28.1%) as in women (13.8%), and increased with age in females, and males <60 years of age. Multivariate analysis showed that several risk factors were profoundly associated with the prevalence of FLD, including male sex, old age, obesity, hyperlipidaemia (cholesterol or triglyceride), fasting hyperglycemia and hypertension.
CONCLUSION: The prevalence of FLD in the Shuiguohu district of Wuhan city, central China, was shown to have increased during the 10-year period, 1995 to 2004. The FLD was found to be closely associated with sex, age, obesity and other metabolic syndrome features.

Entities:  

Mesh:

Year:  2007        PMID: 17344575      PMCID: PMC2599979          DOI: 10.1136/pgmj.2006.052258

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  24 in total

Review 1.  Nonalcoholic fatty liver disease.

Authors:  Paul Angulo
Journal:  N Engl J Med       Date:  2002-04-18       Impact factor: 91.245

Review 2.  AGA technical review on nonalcoholic fatty liver disease.

Authors:  Arun J Sanyal
Journal:  Gastroenterology       Date:  2002-11       Impact factor: 22.682

3.  [Diagnostic criteria of nonalcoholic fatty liver disease].

Authors: 
Journal:  Zhonghua Gan Zang Bing Za Zhi       Date:  2003-02

4.  [Diagnostic criteria of alcoholic liver disease].

Authors: 
Journal:  Zhonghua Gan Zang Bing Za Zhi       Date:  2003-02

5.  Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.

Authors:  G Marchesini; M Brizi; G Bianchi; S Tomassetti; E Bugianesi; M Lenzi; A J McCullough; S Natale; G Forlani; N Melchionda
Journal:  Diabetes       Date:  2001-08       Impact factor: 9.461

6.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

Authors:  Giulio Marchesini; Elisabetta Bugianesi; Gabriele Forlani; Fernanda Cerrelli; Marco Lenzi; Rita Manini; Stefania Natale; Ester Vanni; Nicola Villanova; Nazario Melchionda; Mario Rizzetto
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

7.  Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults.

Authors:  Seung H Park; Woo K Jeon; Sang H Kim; Hong J Kim; Dong I Park; Yong K Cho; In K Sung; Chong I Sohn; Dong K Keum; Byung I Kim
Journal:  J Gastroenterol Hepatol       Date:  2006-01       Impact factor: 4.029

8.  Fatty liver in non-alcoholic non-overweight Japanese adults: incidence and clinical characteristics.

Authors:  Katsuhisa Omagari; Yoshiko Kadokawa; Jun-Ichi Masuda; Ichiei Egawa; Takafumi Sawa; Hiroaki Hazama; Kazuo Ohba; Hajime Isomoto; Yohei Mizuta; Kenji Hayashida; Kunihiko Murase; Takehiko Kadota; Ikuo Murata; Shigeru Kohno
Journal:  J Gastroenterol Hepatol       Date:  2002-10       Impact factor: 4.029

9.  Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States.

Authors:  Constance E Ruhl; James E Everhart
Journal:  Gastroenterology       Date:  2003-01       Impact factor: 22.682

10.  Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein.

Authors:  Hitoshi Nishizawa; Iichiro Shimomura; Ken Kishida; Norikazu Maeda; Hiroshi Kuriyama; Hiroyuki Nagaretani; Morihiro Matsuda; Hidehiko Kondo; Naoki Furuyama; Shinji Kihara; Tadashi Nakamura; Yoshihiro Tochino; Tohru Funahashi; Yuji Matsuzawa
Journal:  Diabetes       Date:  2002-09       Impact factor: 9.461

View more
  13 in total

1.  The prevalence and adverse profiles of fatty liver disease among different ethnic public servants in Urumqi of Xinjiang Uygur Autonomous Region in China.

Authors:  Dan Chen; Jie Guan; Xiang Xie; Wei-Yun Zhao; Palida Abulaiti; Yu Wang; Zhi-Qin Cheng; Jing Zhang; Ying Gao
Journal:  Int J Clin Exp Med       Date:  2015-06-15

Review 2.  Prevalence of fatty liver disease and the economy in China: A systematic review.

Authors:  Jin-Zhou Zhu; Qin-Yi Zhou; Yu-Ming Wang; Yi-Ning Dai; Jiang Zhu; Chao-Hui Yu; You-Ming Li
Journal:  World J Gastroenterol       Date:  2015-05-14       Impact factor: 5.742

Review 3.  The future liver of the Asia pacific: fatter and firmer from more fructose and fortune?

Authors:  Suzanne E Mahady; Jacob George
Journal:  J Clin Exp Hepatol       Date:  2012-12-28

4.  Fatty liver disease index: a simple screening tool to facilitate diagnosis of nonalcoholic fatty liver disease in the Chinese population.

Authors:  Shi Fuyan; Leng Jing; Cao Wenjun; Tan Zhijun; Meng Weijing; Wang Suzhen; Xu Yongyong
Journal:  Dig Dis Sci       Date:  2013-07-31       Impact factor: 3.199

5.  Sex hormone affects the severity of non-alcoholic steatohepatitis through the MyD88-dependent IL-6 signaling pathway.

Authors:  Guangda Xin; Shaoyou Qin; Song Wang; Xu Wang; Yonggui Zhang; Jiangbin Wang
Journal:  Exp Biol Med (Maywood)       Date:  2015-03-18

6.  Epidemiology of a fast emerging disease in the Asia-Pacific region: non-alcoholic fatty liver disease.

Authors:  Chan Wah-Kheong; Goh Khean-Lee
Journal:  Hepatol Int       Date:  2012-06-15       Impact factor: 6.047

Review 7.  Nonalcoholic fatty liver disease: a review and update.

Authors:  Jeffrey R Lewis; Smruti R Mohanty
Journal:  Dig Dis Sci       Date:  2010-01-26       Impact factor: 3.199

8.  Metabolomics profiling to investigate the pharmacologic mechanisms of berberine for the treatment of high-fat diet-induced nonalcoholic steatohepatitis.

Authors:  Jian Li; Zezhou Liu; Mingxing Guo; Kejia Xu; Miao Jiang; Aiping Lu; Xiaoyan Gao
Journal:  Evid Based Complement Alternat Med       Date:  2015-04-22       Impact factor: 2.629

Review 9.  Obesity as the common soil of non-alcoholic fatty liver disease and diabetes: Role of adipokines.

Authors:  Elaine Hui; Aimin Xu; Hong Bo Yang; Karen S L Lam
Journal:  J Diabetes Investig       Date:  2013-05-06       Impact factor: 4.232

10.  Association of adult weight gain and nonalcoholic fatty liver in a cross-sectional study in Wan Song Community, China.

Authors:  W-J Zhang; L-L Chen; J Zheng; L Lin; J-Y Zhang; X Hu
Journal:  Braz J Med Biol Res       Date:  2014-01-24       Impact factor: 2.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.